EVIDENCE. COMPARISONS. CLEAR NEXT STEPS.FOR US CLINIC TEAMS PROCUREMENT RESEARCH
Direct questions

28. Should a clinic use one pharmacy or multiple partners?

Dose Diligence research deskSection 01 · Page 28 of 34Last updated 17 Nov 2026

Use enough independent capability to manage the failures you cannot tolerate, without creating unnecessary fragmentation. Two commercial brands do not constitute meaningful redundancy if both depend on the same dispensing facility or critical system. This is a proposed resilience principle, not a measured industry finding.

Build a dependency map covering:

  • Producing or distributing entities.
  • Dispensing locations.
  • Prescription-routing and payment systems.
  • Shipping carriers and geographic exposure.
  • Customer-support teams.
  • Product and state restrictions.

Then test specific scenarios: a partner stops accepting prescriptions, a state permission changes, a product is recalled, a system becomes unavailable or a programme price changes.

For each scenario, record affected patient count, time to next expected supply, verified alternative capacity and the owner of patient communications.

A backup is operationally credible only after evidence review and a successful test. Do not pay for exclusivity that prevents use of a clinically and legally appropriate alternative during a service failure without an explicit exception.

Sources cited on this page

    See the section’s source register for the research context.

    Section sources →